The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Eli Lilly Nederland B.V.EU/1/14/944/001-004

Main Information

Trade NameAbasaglar
Active SubstancesInsulin glargine
Dosage FormSolution for injection in cartridge
Licence HolderEli Lilly Nederland B.V.
Licence NumberEU/1/14/944/001-004

Group Information

ATC CodeA10AE Insulins and analogues for injection, long-acting
A10AE04 insulin glargine


License statusAuthorised
Licence Issued09/09/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back